FSSAI suspends licences of six nutraceutical makers
India's food regulator suspended the FSSAI licences of six nutraceutical manufacturers for serious food safety violations, a warning for supplement brands and the retailers that stock them.
The short answer
FSSAI has initiated action, including suspension of licences, against six nutraceutical manufacturers, including Airen Herbals and Aquabliss Lifesciences, over violations such as poor hygiene, missing records and use of expired or unapproved ingredients, according to a social media post attributed to the regulator this week. For D2C supplement brands and retailers, the action shows that supplier verification is now a core compliance risk, not a back-office detail.
Key takeaways
- FSSAI has initiated action, including suspension of licences, against six nutraceutical manufacturers over serious food safety violations, according to a social media post attributed to the regulator this week.
- The companies named are Airen Herbals, Aquabliss Lifesciences, Raskam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare and Vedant Remedies.
- Violations cited include poor hygiene, missing records, use of an unapproved ingredient and use of expired materials.
- FSSAI and state food safety departments inspected nearly 56,431 food establishments between 1 September and 5 November, according to the regulator.
- D2C brands and retailers that source from contract manufacturers face listing, inventory and trust risk when a supplier's licence is subject to action.
India's food regulator has initiated action, including suspension of licences, against six nutraceutical manufacturers over serious food safety violations, according to a social media post attributed to the Food Safety and Standards Authority of India this week. The companies named are Airen Herbals, Aquabliss Lifesciences, Raskam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare and Vedant Remedies.
The action matters well beyond those six factories. Nutraceuticals is one of the fastest-growing categories in Indian consumer health, and a large share of it is sold through D2C websites, marketplaces and pharmacies that rarely own the plant where the capsules and syrups are made. When a regulator initiates action against a manufacturer's licence, the brand on the label can lose stock, listings and customer trust overnight.
What exactly did FSSAI find at these six manufacturers?
The reasons vary by company, according to the regulator's post. Airen Herbals was pulled up over its Lycowey Syrup and Maxford Knee Relief products. Aquabliss Lifesciences and Ambico Ayurvedic Healthcare were both cited for poor sanitary and hygienic conditions at their manufacturing premises. Raskam Healthcare faced action for not maintaining the required records and for using an unapproved ingredient. Supercure Biotech's violations related to its Gemkolin capsules, Vitamin E capsule and Superbiotic capsule. Vedant Remedies was cited for using expired materials and for sanitation deficiencies, among other issues.
Sources do not report on company comment, and the regulator's post does not state the length of each suspension or publish the full inspection reports. That leaves an important question open: whether these are paperwork failures that can be fixed quickly or deeper process problems that take months to correct.
Why does this matter for India's supplement brands?
A nutraceutical, in Indian regulation, is a food product formulated to supplement the diet, sold as capsules, tablets, powders or syrups. It sits under FSSAI rules rather than drug rules, which is why action against a licence can halt sales immediately.
The category has attracted a wave of D2C brands selling protein powders, multivitamins, sleep aids and joint-support products, often through contract manufacturers. That asset-light model is efficient. It also concentrates risk: if one contract manufacturer faces action, every brand sourcing from that plant is exposed, whether or not its own product was named.
FSSAI has been raising the tempo of enforcement through the year. Along with state food safety departments, it recently inspected nearly 56,431 food establishments in a nationwide drive between 1 September and 5 November, timed around the festival season, according to the regulator. It has also cracked down against alcoholic beverage and energy drink makers, according to the regulator. The pattern is clear: inspections are becoming more frequent, and enforcement actions are being announced publicly.
What should D2C brands and retailers verify in their supply chain?
If you run a D2C brand or a retail chain that stocks supplements, the starting point is the licence itself. Ask for the manufacturer's FSSAI licence number and check that the product category on the licence matches what is being made. A licence for one product type does not cover another.
- Licence validity and scope: confirm the manufacturer's licence is current and covers nutraceutical categories, not just general food.
- Site records: ask for batch records, raw material purchase records and testing reports. Missing records were enough to trigger action against one of the six companies.
- Ingredient approvals: verify that every ingredient used is permitted for that product category. Use of an unapproved ingredient was cited in one case.
- Shelf-life discipline: check how expired raw materials are segregated and disposed of. Expired materials were cited against one manufacturer.
- Hygiene audits: request recent inspection or audit findings on sanitation, not just a certificate.
For retailers, the practical step is to map every SKU to its manufacturer and licence number, then flag any SKU whose plant has been named in a regulatory action. Marketplace sellers carry a similar duty: per Source 1, FSSAI has increased enforcement against e-commerce companies.
Who bears the cost when a licence is suspended?
The manufacturer loses production and revenue first. But the brand that owns the label usually absorbs the customer-facing damage: returns, delistings, refunds and the slower cost of rebuilding trust. Retailers who have paid for inventory may be left with stock they cannot legally sell if the suspension covers those batches.
This is the trade-off in the contract-manufacturing model. Brands that invest in supplier audits and keep documentation may pay more per unit, but they have a paper trail when a regulator calls. In this author's analysis, brands that optimise only on cost are the ones most exposed when a plant is suspended.
What to watch next
Three things will decide how far this story goes. First, whether the six companies respond publicly and whether any suspension is lifted after corrective action. Second, whether FSSAI names the brands that used these manufacturers, which would widen the impact across D2C storefronts and retail shelves; this is the author's view of a possible development, not an indication of regulatory intent. Third, whether the regulator extends its inspection drive into the supplement category with the same intensity it has shown in beverages and energy drinks.
For founders and retail buyers, the lesson is straightforward. Supplier compliance is now a commercial risk, not a legal formality. The brands that can show a clean licence, a clean audit and a clean batch record will find it easier to stay on shelves.
In this story
Frequently asked questions
Which companies faced FSSAI action?
FSSAI named Airen Herbals, Aquabliss Lifesciences, Raskam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare and Vedant Remedies. The regulator said the action included suspension of licences over serious food safety violations.
What violations were cited?
The regulator cited poor sanitary and hygienic conditions at manufacturing premises, non-maintenance of records, use of an unapproved ingredient, use of expired materials and product-specific issues at some of the six companies.
Does action against a manufacturer's licence affect the brands that buy from these manufacturers?
It can. Brands that source from a plant facing licence action may face stock shortages, delistings and customer returns, even if their own product was not named in the action. Retailers should map SKUs to manufacturer licences.
How many food establishments did FSSAI inspect recently?
FSSAI said nearly 56,431 food establishments were inspected across states between 1 September and 5 November as part of a nationwide enforcement drive during the festival season.
What should a D2C supplement brand check in its supply chain?
Verify the manufacturer's FSSAI licence and its product scope, review batch and raw material records, confirm ingredient approvals, check how expired materials are handled and ask for recent hygiene audit findings.
Based on company announcements, filings and reporting by ET HealthWorld and BusinessLine.
